RARE ▼ -5.0% - Ultragenyx Pharmaceutical Inc.
$RARE - Ultragenyx Reports Third Quarter 2026 Financial Results, Announces Substantial Expense Reductions, and Reaffirms Profitability in 2027
03-NOV-2026 04:01 PM ET
Share this post
More filings for $RARE
RARE - Ultragenyx Pharmaceutical Inc. - SEC Filing Update (30-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 30, 2026RARE ▲ +4.1% - Ultragenyx Pharmaceutical Inc.Oct 27, 2026RARE - Ultragenyx Pharmaceutical Inc. - SEC Filing Update (20-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 20, 2026RARE ▲ +2.1% - Ultragenyx Pharmaceutical Inc.Oct 14, 2026RARE ▲ +12.2% - Ultragenyx Pharmaceutical Inc.Sep 17, 2026RARE ▼ -42.8% - Ultragenyx Pharmaceutical Inc.Sep 2, 2026
View full $RARE filing history →💬 Comments
Loading comments…
Leave a comment